Histochemistry and Cell Biology

, Volume 133, Issue 4, pp 367–373 | Cite as

Effects of dissolucytotic gold ions on recovering brain lesions

  • Gorm DanscherEmail author
  • Agnete Larsen


Recent experimental research has shown that metallic gold releases charged gold atoms when placed intracerebrally and that the liberated gold ions affect inflammation in the brain. The observations suggest that metallic gold can be used as a safe suppressor of inflammation in the central nervous system.


Autometallography (AMG) Dissolucytosis Metallic gold Gold ion inflammation Lesion Neuronal stem cells (NSCs) Brain Central nervous system (CNS) 



The authors acknowledge the technical assistance of Mrs. Karin Wiedemann and Mr. Albert Meier.


  1. Aktas O, Waiczies S, Zipp F (2007) Neurodegeneration in autoimmune demyelination: recent mechanistic insights reveal novel therapeutic targets. J Neuroimmunol 184:17–26CrossRefPubMedGoogle Scholar
  2. Amatore C, Arbault S, Bouton C, Drapier JC, Ghandour H, Koh AC (2008) Real-time amperometric analysis of reactive oxygen and nitrogen species released by single immunostimulated macrophages. Chembiochem 9:1472–1480CrossRefPubMedGoogle Scholar
  3. Back T, Schüler OG (2004) The natural course of lesion development in brain ischemia. Acta Neurochir Suppl 89:55–61PubMedGoogle Scholar
  4. Barker RA, Widner H (2004) Immune problems in central nervous system cell therapy. NeuroRx 1:472–481CrossRefPubMedGoogle Scholar
  5. Bendayan M (1980) Use of the protein A-gold technique for the morphological study of vascular permeability. J Histochem Cytochem 28:1251–1254PubMedGoogle Scholar
  6. Brunk UT, Dalen H, Roberg K, Hellquist HB (1997) Photo-oxidative disruption of lysosomal membranes causes apoptosis of cultured human fibroblasts. Free Radic Biol Med 23:616–626CrossRefPubMedGoogle Scholar
  7. Burkhardt D, Stephens RW, Ghosh P, Taylor TK (1978) Inhibition of synovial fluid lysosomal glycosidases by anti-arthritic gold preparations. Agents Actions 8:251–257CrossRefPubMedGoogle Scholar
  8. Chew LJ, Takanohashi A, Bell M (2006) Microglia and inflammation: impact on developmental brain injuries. Ment Retard Dev Disabil Res Rev 12:105–112CrossRefPubMedGoogle Scholar
  9. Choi M, Driscoll CF (2004) Fabrication of a custom eyelid implant prosthesis: a clinical report. J Prosthodont 13:101–103CrossRefPubMedGoogle Scholar
  10. Danscher G (1981) Localization of gold in biological tissue. A photochemical method for light and electron microscopy. Histochemistry 71:81–88CrossRefPubMedGoogle Scholar
  11. Danscher G (1991) Histochemical tracing of zinc, mercury, silver and gold. Prog Histochem Cytochem 23:273–285PubMedGoogle Scholar
  12. Danscher G (2002) In vivo liberation of gold ions from gold implants. Autometallographic tracing of gold in cells adjacent to metallic gold. Histochem Cell Biol 117:447–452CrossRefPubMedGoogle Scholar
  13. Danscher G (2010) Medicament and method of treatment of patients with heavy metals. United States Patent 7,655,261 B2, 2 Feb 2010Google Scholar
  14. Danscher G, Nørgaard JOR (1983) Light microscopic visualization of colloidal gold on resin-embedded tissue. J Histochem Cytochem 31:1394–1398PubMedGoogle Scholar
  15. Danscher G, Nørgaard JOR (1985) Ultrastructural autometallography: a method for silver amplification of catalytic metals. J Histochem Cytochem 33:706–710PubMedGoogle Scholar
  16. Danscher G, Stoltenberg M (2006) Autometallography (AMG). Silver enhancement of quantum dots resulting from 1) metabolism of toxic metals in animals and humans, 2) in vivo, in vitro and immersion created zinc-sulphur/zinc-selenium nanocrystals, 3) metal ions liberated from metal implants and particles. Prog Histochem Cytochem 41:57–140CrossRefPubMedGoogle Scholar
  17. Danscher G, Hansen HJ, Møller-Madsen B (1984) Energy dispersive X-ray analysis of tissue gold after silver amplification by physical development. Histochemistry 81:283–285CrossRefPubMedGoogle Scholar
  18. Davies M, Lloyd JB, Beck F (1971) The effect of trypan blue, suramin and aurothiomalate on the breakdown of 125 I-labelled albumin within rat liver lysosomes. Biochem J 121:21–26PubMedGoogle Scholar
  19. Debons AF, Das KC, Fuhr B, Siclari E (1982a) Inhibition by hypophysectomy of the hyperphagia and obesity following gold thioglucose. Physiol Behav 29:695–699CrossRefPubMedGoogle Scholar
  20. Debons AF, Siclari E, Das KC, Fuhr B (1982b) Gold thioglucose-induced hypothalamic damage, hyperphagia, and obesity: dependence on the adrenal gland. Endocrinology 110:2024–2029CrossRefPubMedGoogle Scholar
  21. Faulk WP, Taylor GM (1971) An immunocolloid method for the electron microscope. Immunochemistry 8:1081–1083CrossRefPubMedGoogle Scholar
  22. Felson DT, Anderson JJ, Meenan RF (1990) The comparative efficacy and toxicity of second-line drugs in rheumatoid arthritis. Results of two metaanalyses. Arthritis Rheum 33:1449–1461CrossRefPubMedGoogle Scholar
  23. Fleming CJ, Salisbury EL, Kirwan P, Painter DM, Barnetson RS (1996) Chrysiasis after low-dose gold and UV light exposure. J Am Acad Dermatol 34:349–351CrossRefPubMedGoogle Scholar
  24. Giulian D, Corpuz M, Chapman S, Mansouri M, Robertson C (1993) Reactive mononuclear phagocytes release neurotoxins after ischemic and traumatic injury to the central nervous system. J Neurosci Res 36:681–693CrossRefPubMedGoogle Scholar
  25. Habal MB (1979) Current status of biomaterial’s clinical applications in plastic and reconstructive surgery. Biomater Med Devices Artif Organs 7:229–241PubMedGoogle Scholar
  26. Hashimoto K, Whitehurst CE, Matsubara T, Hirohata K, Lipsky PE (1992) Immunomodulatory effects of therapeutic gold compounds. Gold sodium thiomalate inhibits the activity of T cell protein kinase C. J Clin Invest 89:1839–1848CrossRefPubMedGoogle Scholar
  27. Hashizume H, Seo N, Ito T, Takigawa M, Yagi H (2008) Promiscuous interaction between gold-specific T cells and APCs in gold allergy. J Immunol 181:8096–8102PubMedGoogle Scholar
  28. Holgate CS, Jackson P, Cowen PN, Bird CC (1983) Immunogold-silver staining: new method of immunostaining with enhanced sensitivity. J Histochem Cytochem 31:938–944PubMedGoogle Scholar
  29. Hostýnek JJ (1997) Gold: an allergen of growing significance. Food Chem Toxicol 35:839–844CrossRefPubMedGoogle Scholar
  30. Inglese M, Mancardi GL, Pagani E, Rocca MA, Murialdo A, Saccardi R, Comi G, Filippi M (2004) Brain tissue loss occurs after suppression of enhancement in patients with multiple sclerosis treated with autologous haematopoietic stem cell transplantation. J Neurol Neurosurg Psychiatry 75:643–644PubMedGoogle Scholar
  31. Larsen A, Stoltenberg M, Danscher G (2007) In vitro liberation of charged gold atoms: autometallographic tracing of gold ions released by macrophages grown on metallic gold surfaces. Histochem Cell Biol 128:1–6CrossRefPubMedGoogle Scholar
  32. Larsen A, Kolind K, Pedersen DS, Doering P, Pedersen MO, Danscher G, Penkowa M, Stoltenberg M (2008) Gold ions bio-released from metallic gold particles reduce inflammation and apoptosis and increase the regenerative responses in focal brain injury. Histochem Cell Biol 130:681–692CrossRefPubMedGoogle Scholar
  33. Liu B, Hong JS (2003) Neuroprotective effect of naloxone in inflammation-mediated dopaminergic neurodegeneration. Dissociation from the involvement of opioid receptors. Methods Mol Med 79:43–54PubMedGoogle Scholar
  34. McGirr EE, Browne CD, Champion GD, Day RO, Sambrook PN (1984) Aurothioglucose in rheumatoid arthritis. Outcome of treatment in patients intolerant of sodium aurothiomalate. Med J Aust 141:349–351PubMedGoogle Scholar
  35. Merchant B (1998) Gold, the noble metal and the paradoxes of its toxicology. Biologicals 26:49–59CrossRefPubMedGoogle Scholar
  36. Mhatre AN, Li Y, Feng L, Gasperin A, Lalwani AK (2004) SDHB, SDHC, and SDHD mutation screen in sporadic and familial head and neck paragangliomas. Clin Genet 66:461–466CrossRefPubMedGoogle Scholar
  37. Møller-Madsen B, Mogensen SC, Danscher G (1984) Ultrastructural localization of gold in macrophages and mast cells exposed to aurothioglucose. Exp Mol Pathol 40:148–154CrossRefPubMedGoogle Scholar
  38. Møller-Madsen B, Danscher G, Uldbjerg N, Allen JG (1987) Autometallographic demonstration of gold in human fetal liver and placenta. Rheumatol Int 7:47–48CrossRefPubMedGoogle Scholar
  39. Ogura T, Takaoka M, Yamauchi T, Oishi T, Mimura Y, Hashimoto M, Asano N, Yamamura M, Otsuka F, Makino H, Ota Z, Takahashi K (1996) Changes in urinary enzyme activity and histochemical findings in experimental tubular injury induced by gold sodium thiomalate. J Med 27:41–55PubMedGoogle Scholar
  40. Pantano P, Mainero C, Caramia F (2006) Functional brain reorganization in multiple sclerosis: evidence from fMRI studies. J Neuroimaging 16:104–114CrossRefPubMedGoogle Scholar
  41. Pedersen MO, Larsen A, Pedersen DS, Stoltenberg M, Penkova M (2009a) Metallic gold treatment reduces proliferation of inflammatory cells, increases expression of VEGF and FGF, and stimulates cell proliferation in the subventricular zone following experimental traumatic brain injury. Histol Histopathol 24:573–586PubMedGoogle Scholar
  42. Pedersen MO, Larsen A, Pedersen DS, Stoltenberg M, Penkowa M (2009b) Metallic gold reduces TNFα expression, oxidative DNA damage and pro-apoptotic signals after experimental brain injury. Brain Res 1271:103–113CrossRefPubMedGoogle Scholar
  43. Pedersen MO, Larsen A, Stoltenberg M, Penkowa M (2010) Bio-released gold ions modulate expression of neuroprotective and hematopoietic factors after brain injury. Brain Res 1307:1–13CrossRefPubMedGoogle Scholar
  44. Persellin RH, Ziff M (1966) The effect of gold salt on lysosomal enzymes of the peritoneal macrophage. Arthritis Rheum 9:57–65CrossRefPubMedGoogle Scholar
  45. Rasmussen S, Wang Y, Kivisäkk P, Bronson RT, Meyer M, Imitola J, Khoury SJ (2007) Persistent activation of microglia is associated with neuronal dysfunction of callosal projecting pathways and multiple sclerosis-like lesions in relapsing—remitting experimental autoimmune encephalomyelitis. Brain 130:2816–2829CrossRefPubMedGoogle Scholar
  46. Richards DG, McMillin DL, Mein EA, Nelson CD (2002) Gold and its relationship to neurological/glandular conditions. Int J Neurosci 112:31–53CrossRefPubMedGoogle Scholar
  47. Roach TI, Slater SE, White LS, Zhang X, Majerus PW, Brown EJ, Thomas ML (1998) The protein tyrosine phosphatase SHP-1 regulates integrin-mediated adhesion of macrophages. Curr Biol 8:1035–1038CrossRefPubMedGoogle Scholar
  48. Schiønning JD, Poulsen EH, Møller-Madsen B, Danscher G (1992) Autometallographic detection of gold in dorsal root ganglia of rats treated with sodium aurothiomalate. Exp Mol Pathol 56:239–247CrossRefPubMedGoogle Scholar
  49. Sennerby L, Kälebo P, Thomsen P, Albrektsson T (1993) Influence of indomethacin on the regeneration of cortical bone within titanium implants in rabbits. Biomaterials 14:156–158CrossRefPubMedGoogle Scholar
  50. Stierhof YD, Humbel BM, Schwarz H (1991) Suitability of different silver enhancement methods applied to 1 nm colloidal gold particles: an immunoelectron microscopic study. J Electron Microsc Tech 17:336–343CrossRefPubMedGoogle Scholar
  51. Stoll G, Jander S, Schroeter M (1998) Inflammation and glial responses in ischemic brain lesions. Prog Neurobiol 56:149–171CrossRefPubMedGoogle Scholar
  52. Svedman C, Ekqvist S, Möller H, Björk J, Pripp CM, Gruvberger B, Holmström E, Gustavsson CG, Bruze M (2009) A correlation found between contact allergy to stent material and restenosis of the coronary arteries. Contact Dermat 60(3):158–164CrossRefGoogle Scholar
  53. Tanigawa N, Sawada S, Kobayashi M (1995) Reaction of the aortic wall to six metallic stent materials. Acad Radiol 2:379–384CrossRefPubMedGoogle Scholar
  54. Tozman EC, Gottlieb NL (1987) Adverse reactions with oral and parenteral gold preparations. Med Toxicol 2:177–189PubMedGoogle Scholar
  55. Traber KE, Okamoto H, Kurono C, Baba M, Saliou C, Soji T, Packer L, Okamoto T (1999) Anti-rheumatic compound aurothioglucose inhibits tumor necrosis factor-alpha-induced HIV-1 replication in latently infected OM10.1 and Ach2 cells. Int Immunol 11:143–150CrossRefPubMedGoogle Scholar
  56. Vernon-Roberts B (1979) Action of gold salts on the inflammatory response and inflammatory cell function. J Rheumatol Suppl 5:120–129PubMedGoogle Scholar
  57. Whitney NP, Eidem TM, Peng H, Huang Y, Zheng JC (2009) Inflammation mediates varying effects in neurogenesis: relevance to the pathogenesis of brain injury and neurodegenerative disorders. J Neurochem 108(6):1343–1359CrossRefPubMedGoogle Scholar
  58. Yamaguchi K, Ushijima H, Hisano M, Inoue Y, Shimamura T, Hirano T, Müller WE (2001) Immunomodulatory effect of gold sodium thiomalate on murine acquired immunodeficiency syndrome. Microbiol Immunol 45:549–555PubMedGoogle Scholar
  59. Yang JP, Merin JP, Nakano T, Kato T, Kitade Y, Okamoto T (1995) Inhibition of the DNA-binding activity of NF-kappa B by gold compounds in vitro. FEBS Lett 361:89–96CrossRefPubMedGoogle Scholar
  60. Yanni G, Nabil M, Farahat MR, Poston RN, Panayi GS (1994) Intramuscular gold decreases cytokine expression and macrophage numbers in the rheumatoid synovial membrane. Ann Rheum Dis 53:315–322CrossRefPubMedGoogle Scholar
  61. Yoshida S, Kato T, Sakurada S, Kurono C, Yang JP, Matsui N, Soji T, Okamoto T (1999) Inhibition of IL-6 and IL-8 induction from cultured rheumatoid synovial fibroblasts by treatment with aurothioglucose. Int Immunol 11:151–158CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2010

Authors and Affiliations

  1. 1.Department of Anatomy and NeurobiologyUniversity of AarhusAarhus CDenmark
  2. 2.Berlock ApSAarhus CDenmark

Personalised recommendations